Drug Development: Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options Is Infrequently Used

Publisher: United States. Government Accountability Office
Coverage: November 19, 2021

Volumes:

GAO-22-105042 (2021-11-19)